                                                                                                                                   I




                                  113TH CONGRESS
                                     1ST SESSION                          H. R. 460
                                  To amend title XXVII of the Public Health Service Act to limit co-payment,
                                      coinsurance, or other cost-sharing requirements applicable to prescription
                                      drugs in a specialty drug tier to the dollar amount (or its equivalent)
                                      of such requirements applicable to prescription drugs in a non-preferred
                                      brand drug tier, and for other purposes.




                                                IN THE HOUSE OF REPRESENTATIVES
                                                               FEBRUARY 4, 2013
                                  Mr. MCKINLEY (for himself, Mrs. CAPPS, Mrs. CAPITO, Mr. YOUNG of Flor-
                                      ida, Mr. MORAN, Mr. WOLF, Mr. TONKO, Mr. RUNYAN, Mr. CONYERS,
                                      Ms. BONAMICI, Mr. CICILLINE, Mr. DEFAZIO, Mr. MICHAUD, Mr. FARR,
                                      Ms. PINGREE of Maine, Mr. RANGEL, and Mr. CRENSHAW) introduced
                                      the following bill; which was referred to the Committee on Energy and
                                      Commerce




                                                                            A BILL
                                  To amend title XXVII of the Public Health Service Act
                                     to limit co-payment, coinsurance, or other cost-sharing
                                     requirements applicable to prescription drugs in a spe-
                                     cialty drug tier to the dollar amount (or its equivalent)
                                     of such requirements applicable to prescription drugs
                                     in a non-preferred brand drug tier, and for other pur-
                                     poses.
                                    1              Be it enacted by the Senate and House of Representa-
                                    2 tives of the United States of America in Congress assembled,





                                    1     SECTION 1. SHORT TITLE.                            2
                                    2              This Act may be cited as the ‘‘Patients’ Access to
                                    3 Treatments Act of 2013’’.
                                    4     SEC. 2. COST-SHARING REQUIREMENTS APPLICABLE TO
                                    5                             PRESCRIPTION DRUGS IN A SPECIALTY DRUG
                                    6                             TIER.

                                    7              (a) IN GENERAL.—Subpart II of part A of title
                                    8 XXVII of the Public Health Service Act (42 U.S.C. 300gg
                                    9 et seq.) is amended by adding at the end the following:
                                  10      ‘‘SEC. 2719B. COST-SHARING REQUIREMENTS APPLICABLE
                                  11                              TO PRESCRIPTION DRUGS IN A SPECIALTY
                                  12                              DRUG TIER.

                                  13               ‘‘(a) REQUIREMENT.—A group health plan, or a
                                  14 health insurance issuer offering group or individual health
                                  15 insurance, that provides coverage for prescription drugs
                                  16 and uses a formulary or other tiered cost-sharing struc-
                                  17 ture shall not impose cost-sharing requirements applicable
                                  18 to prescription drugs in a specialty drug tier that exceed
                                  19 the dollar amount (or its equivalent) of cost-sharing re-
                                  20 quirements applicable to prescription drugs in a non-pre-
                                  21 ferred brand drug tier (or prescription drugs in a brand
                                  22 drug tier if there is no non-preferred brand drug tier).
                                  23               ‘‘(b) SPECIAL RULE.—If a formulary used by a group
                                  24 health plan or a health insurance issuer offering group or




                                  25 individual health insurance contains more than one non-
                                  26 preferred brand drug tier, then the requirements of sub-
                                              •HR 460 IH

                                                                                             3
                                    1 section (a) shall be applied with respect to the non-pre-
                                    2 ferred brand drug tier for which beneficiary cost-sharing
                                    3 is lowest.
                                    4              ‘‘(c) DEFINITIONS.—In this section:
                                    5                        ‘‘(1) The term ‘cost-sharing’ includes co-pay-
                                    6              ment and coinsurance.
                                    7                        ‘‘(2) The term ‘drug tier’ means, with respect
                                    8              to a group health plan or health insurance issuer of-
                                    9              fering group or individual health insurance coverage
                                  10               that uses a formulary or other cost-sharing struc-
                                  11               ture, a category of drugs—
                                  12                                  ‘‘(A) within such formulary or structure
                                  13                         for which the total dollar amount of cost-shar-
                                  14                         ing requirements for any drug does not vary by
                                  15                         more than ten percent from the total dollar
                                  16                         amount of cost-sharing requirements for any
                                  17                         other drug; and
                                  18                                  ‘‘(B) that are prescription drugs.
                                  19                         ‘‘(3) The term ‘non-preferred brand drug tier’
                                  20               means, with respect to a group health plan or health
                                  21               insurance issuer offering group or individual health
                                  22               insurance coverage that uses a formulary or other
                                  23               tiered cost-sharing structure, a category of drugs—
                                  24                                  ‘‘(A) within a drug tier in such formulary




                                  25                         or structure for which beneficiary cost-sharing
                                              •HR 460 IH

                                                                                             4
                                    1                        is greater than drug tiers for generic drugs or
                                    2                        preferred brand drugs in the formulary or
                                    3                        structure;
                                    4                                 ‘‘(B) that are prescription drugs; and
                                    5                                 ‘‘(C) that are not included within a spe-
                                    6                        cialty drug tier.
                                    7                        ‘‘(4) The term ‘prescription drug’ means—
                                    8                                 ‘‘(A) a drug subject to section 503(b)(1) of
                                    9                        the Federal Food, Drug, or Cosmetic Act; and
                                  10                                  ‘‘(B) includes a drug described in subpara-
                                  11                         graph (A) that is a biological product (as de-
                                  12                         fined in section 351(i) of this Act).
                                  13                         ‘‘(5) The term ‘specialty drug tier’ means, with
                                  14               respect to a group health plan or health insurance
                                  15               issuer offering group or individual health insurance
                                  16               coverage that uses a formulary or other tiered cost-
                                  17               sharing structure, a category of drugs—
                                  18                                  ‘‘(A) within a drug tier in such formulary
                                  19                         or structure for which beneficiary cost-sharing
                                  20                         is greater than drug tiers for generic drugs,
                                  21                         preferred brand drugs, or non-preferred drugs
                                  22                         in the plan’s formulary; and
                                  23                                  ‘‘(B) that are prescription drugs.’’.
                                  24               (b) EFFECTIVE DATE.—Section 2719B of the Public




                                  25 Health Service Act, as added by subsection (a), applies
                                              •HR 460 IH

                                                                                             5
                                    1 to plan years beginning on or after the date of the enact-
                                    2 ment of this Act.
                                              •HR 460 IH                                   Æ
